Job Description

• Preparation and review of test procedure, development reports, method validation protocol and LNBs.
• Perform calibration of the analytical instruments as per calibration schedule.
• Follow the standard practices-cGLP during lab experiments.
• Analytical method development and validation for quantification of genotoxic impurities by LCMS, GCMS and ICPMS.
• Analytical method development, validation, and sample analysis for Extractables and Leachables using HPLC, LCMS, GCMS and ICPMS.
• Identification and characterization of unknown impurities by LCMS.
• Follow the GxP (GMP, GDP, and GLP) for all processes.
• Maintain hygienic condition in respective department.
• Standard management.
• Review of routine analytical activity (Peer Reviewer)
• Ensure use of personal protective equipment, attend EHS training, send waste to concerned person, and comply EHS requirement.


In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth.
Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices.



Equal employment opportunity Piramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer. We do not discriminate based upon race, ethnicity, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, genetics, or other applicable legally protected characteristics.



We base our employment decisions on merit considering qualifications, skills, performance, and achievements. We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters, including recruitment, selection, training, placement, promotion, demotion, compensation and benefits, transfers, terminations, and working conditions, including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice.

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines, gene therapies, and monoclonal antibodies, made possible through Piramal Pharma Limited's investment in Yapan Bio Private Limited. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovators and generic companies worldwide.